Article Text

Download PDFPDF
Mechanism related to reduction of intraocular pressure by melanocortins in rabbits
  1. N Naveha,
  2. A Kaplan-Messasa,
  3. J Marshallb
  1. aGoldschleger Eye Research Institute, Tel Aviv University School of Medicine, Sheba Medical Center, Israel, bRayne's Institute, St Thomas's Hospital, London, UK
  1. Professor N Naveh, 15 Rav Ashi St, Tel Aviv 69395, Israelhnave{at}zahav.net.il

Abstract

AIM To investigate whether the ocular hypotensive effect of alpha melanocyte stimulating hormone (MSH) is related to eicosanoids or cyclic AMP (cAMP).

METHODS Intraocular pressure (IOP) readings were taken at a similar time on the day before and after a single dose of topical MSH. Changes in the levels of prostaglandin E2 (PGE2) and prostacyclin in incubated iris ciliary body (ICB) explants were measured by specific radioimmunoassay (RIA). Incubated ICB explants were exposed to MSH or adrenaline (epinephrine) for a week. In addition, cAMP levels in the medium were determined following short term incubation using RIA.

RESULTS A significant dose related reduction in IOP was noted with topical MSH (mean (SD) maximal effect 4.5 (0.1) mm Hg (21%); p<0.001v appropriate baseline) which persisted up to 6 hours (p=0.05). MSH treated ICB explants showed a 1.5-fold increase in PGE2 and prostacyclin levels (p<0.001 for each parameter) while cAMP levels were increased twofold (p<0.001).

CONCLUSIONS A single application of MSH caused a sustained dose related ocular hypotensive effect with no side effects. An increase in eicosanoid and cAMP levels following ICB exposure to MSH indicated their involvement in MSH induced ocular hypotension. MSH and its analogues might have clinical relevance as antiglaucoma drugs with fewer side effects because of their antiallergic and anti-inflammatory properties.

  • melanocyte stimulating hormone (MSH)
  • intraocular pressure
  • cAMP
  • prostaglandins

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  •  NN and JM have a proprietary interest in the subject.